Measurement of placental perfusion by dynamic contrast-enhanced MRI at 4.7 T

Investigative Radiology

Volumn 48, Issue 7, 2013, Pages 535-542

  Alison, Marianne ^a,b   Quibel, Thibault ^a   Balvay, Daniel ^a,c   Autret, Gwennhael ^a,c   Bourillon, Camille ^a,d   Chalouhi, Gihad E ^a,e   Deloison, Benjamin ^a,e   Salomon, Laurent J ^a,e   Cuenod, Charles André ^a,d   Clement, Olivier ^a,c,d   Siauve, Nathalie ^a,d  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

contrast media; functional magnetic resonance imaging; perfusion; placental insufficiency

Indexed keywords

GADOLINIUM CHELATE; GADOTERATE MEGLUMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FETUS; IMAGE ANALYSIS; IN VITRO STUDY; MICROCIRCULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA; PLACENTA CIRCULATION; PLACENTA PERFUSION; PRIORITY JOURNAL; RAT; UTERUS HORN; VASCULAR PEDICLE;

EID: 84879994034     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3182856a25     Document Type: Article

References (60)

1. Keator CS, Lindner JR, Belcik JT, et al. Contrast-enhanced ultrasound reveals real-time spatial changes in vascular perfusion during early implantation in the macaque uterus. Fertil Steril. 2011;95:1316-1321.e1311Y1313.
2. Alison M, Chalouhi GE, Autret G, et al. Use of intravoxel incoherent motion MR imaging to assess placental perfusion in a murine model of placental insufficiency. Invest Radiol. 2013;48:17-23.
3. Bonel HM, Stolz B, Diedrichsen L, et al. Diffusion-weighted MR imaging of the placenta in fetuses with placental insufficiency. Radiology. 2010;257:810-819.
4. Moore RJ, Ong SS, Tyler DJ, et al. Spiral artery blood volume in normal pregnancies and those compromised by pre-eclampsia. NMR Biomed. 2008; 21:376-380. (Pubitemid 351771887)
5. Moore RJ, Strachan BK, Tyler DJ, et al. In utero perfusing fraction maps in normal and growth restricted pregnancy measured using IVIM echo-planar MRI. Placenta. 2000;21:726-732.
6. Moore RJ, Issa B, Tokarczuk P, et al. In vivo intravoxel incoherent motion measurements in the human placenta using echo-planar imaging at 0.5 T. Magn Reson Med. 2000;43:295-302. (Pubitemid 30075454)
7. Avni R, Raz T, Biton IE, et al. Unique in utero identification of fetuses in multifetal mouse pregnancies by placental bidirectional arterial spin labeling MRI. Magn Reson Med. 2012;68:560-570.
8. Francis ST, Duncan KR, Moore RJ, et al. Non-invasive mapping of placental perfusion. Lancet. 1998;351:1397-1399. (Pubitemid 28209998)
9. Gowland PA, Francis ST, Duncan KR, et al. In vivo perfusion measurements in the human placenta using echo planar imaging at 0.5 T. Magn Reson Med. 1998;40:467-473. (Pubitemid 28391909)
10. Salomon LJ, Siauve N, Balvay D, et al. Placental perfusion MR imaging with contrast agents in a mouse model. Radiology. 2005;235:73-80. (Pubitemid 40432239)
11. Salomon LJ, Siauve N, Taillieu F, et al. In vivo dynamic MRI measurement of the noradrenaline-induced reduction in placental blood flow in mice. Placenta. 2006;27:1007-1013. (Pubitemid 44204025)
12. Taillieu F, Salomon LJ, Siauve N, et al. Placental perfusion and permeability: simultaneous assessment with dual-echo contrast-enhanced MR imaging in mice. Radiology. 2006;241:737-745. (Pubitemid 46190539)
13. Deloison B, Siauve N, Aimot S, et al. SPIO-enhanced magnetic resonance imaging study of placental perfusion in a rat model of intrauterine growth restriction. BJOG. 2012;119:626-633.
14. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging. 2002;16:407-422. (Pubitemid 35167876)
15. Yankeelov TE, Gore JC. Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev. 2009;3:91-107. (Pubitemid 46773870)
16. Notohamiprodjo M, Reiser MF, Sourbron SP. Diffusion and perfusion of the kidney. Eur J Radiol. 2010;76:337-347.
17. Thomassin-Naggara I, Darai E, Cuenod CA, et al. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging. 2008;28:111-120. (Pubitemid 351956473)
18. Thomassin-Naggara I, Bazot M, Darai E, et al. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology. 2008;248:148-159.
19. Thomassin-Naggara I, Darai E, Nassar-Slaba J, et al. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma. J Comput Assist Tomogr. 2007;31:236-242. (Pubitemid 46573362)
20. Thomassin-Naggara I, Toussaint I, Perrot N, et al. Characterization of complex adnexal masses: value of adding perfusion-and diffusion-weighted MR imaging to conventional MR imaging. Radiology. 2011;258:793-803.
21. Sourbron S. Technical aspects of MR perfusion. Eur J Radiol. 2010;76:304-313.
22. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7:91-101. (Pubitemid 28365643)
23. Thomassin-Naggara I, Balvay D, Aubert E, et al. Quantitative dynamic contrastenhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol. 2012;22:738-745.
24. Thomassin-Naggara I, Balvay D, Cuenod CA, et al. Dynamic contrast-enhanced MR imaging to assess physiologic variations of myometrial perfusion. Eur Radiol. 2010;20:984-994.
25. Kim YS, Lim HK, Kim JH, et al. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonanceguided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Invest Radiol. 2011;46:639-647.
26. de Bazelaire C, Siauve N, Fournier L, et al. Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma. Eur Radiol. 2005;15:2497-2505. (Pubitemid 43153852)
27. Pradel C, Siauve N, Bruneteau G, et al. Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media. Magn Reson Imaging. 2003;21:845-851. (Pubitemid 37377477)
28. Wigglesworth JS. Fetal growth retardation. Animal model: uterine vessel ligation in the pregnant rat. Am J Pathol. 1974;77:347-350.
29. Armitage P, Behrenbruch C, Brady M, et al. Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast. Med Image Anal. 2005;9:315-329. (Pubitemid 40812566)
30. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724. (Pubitemid 41546838)
31. Robert P, Violas X, Santus R, et al. Optimization of a blood pool contrast agent injection protocol for MR angiography. J Magn Reson Imaging. 2005;21:611-619. (Pubitemid 40586761)
32. Barron WM, Stamoutsos BA, Lindheimer MD. Role of volume in the regulation of vasopressin secretion during pregnancy in the rat. J Clin Invest. 1984;73:923-932. (Pubitemid 14132820)
33. Balvay D, Tropres I, Billet R, et al. Mapping the zonal organization of tumor perfusion and permeability in a rat glioma model by using dynamic contrastenhanced synchrotron radiation CT. Radiology. 2009;250:692-702.
34. Brix G, Bahner ML, Hoffmann U, et al. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CTVinitial experience. Radiology. 1999;210:269-276. (Pubitemid 29004315)
35. de Langen AJ, van den Boogaart VE, Marcus JT, et al. Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow. Oncologist. 2008;13:631-644. (Pubitemid 351904908)
36. Balvay D, Frouin F, Calmon G, et al. New criteria for assessing fit quality in dynamic contrast-enhanced T1-weighted MRI for perfusion and permeability imaging. Magn Reson Med. 2005;54:868-877. (Pubitemid 41457058)
37. Cyran CC, von Einem JC, Paprottka PM, et al. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas. Invest Radiol. 2012;47:49-57.
38. Hartono S, Thng CH, Ng QS, et al. High temporal resolution dynamic contrastenhanced MRI at 7 tesla: a feasibility study with mouse liver model. Conf Proc IEEE Eng Med Biol Soc 2011;2011:2788-2791.
39. Han S, Paulsen JL, Zhu G, et al. Temporal/spatial resolution improvement of in vivo DCE-MRI with compressed sensing-optimized FLASH. Magn Reson Imaging. 2012;30:741-752.
40. Heisen M, Fan X, Buurman J, et al. The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data. Magn Reson Med. 2010;63:811-816.
41. Weidensteiner C, RauschM,McSheehy PM, et al. Quantitative dynamic contrastenhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T. J Magn Reson Imaging. 2006;24:646-656. (Pubitemid 44320569)
42. Liang J, Sammet S, Yang X, et al. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Invest Radiol. 2011;45:233-244.
43. Ahn SJ, An CS, Koom WS, et al. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model. Korean J Radiol. 2011;12:722-730.
44. Kozlowski P, Chang SD, Meng R, et al. Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3TVquantitative correlation with biopsy. Magn Reson Imaging. 2011;28:621-628.
45. Lowry M, Zelhof B, Liney GP, et al. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue. Invest Radiol. 2009;44:577-584.
46. Tateishi U, Miyake M, Nagaoka T, et al. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrastenhanced MR imagingVprospective assessment. Radiology. 2012;263:53-63.
47. El Khouli RH, Macura KJ, Kamel IR, et al. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. AJR Am J Roentgenol. 2011;197:1498-1505.
48. Tomlinson TM, Garbow JR, Anderson JR, et al. Magnetic resonance imaging of hypoxic injury to the murine placenta. Am J Physiol Regul Integr Comp Physiol. 2010;298:R312YR319.
49. Yankeelov TE, Luci JJ, Lepage M, et al. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging. 2005;23:519-529. (Pubitemid 40779238)
50. Kashiwagi Y, Nodaira M, Amitani M, et al. Assessment of peripheral tissue perfusion disorder in streptozotocin-induced diabetic rats using dynamic contrast-enhanced MRI. Magn Reson Imaging. 2012;30:254-260.
51. Wang H, Cao Y. Correction of arterial input function in dynamic contrast-enhanced MRI of the liver. J Magn Reson Imaging. 2012;36:411-421.
52. Heilmann M, Kiessling F, Enderlin M, et al. Determination of pharmacokinetic parameters in DCE MRI: consequence of nonlinearity between contrast agent concentration and signal intensity. Invest Radiol. 2006;41:536-543. (Pubitemid 44284189)
53. Webb JA, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15: 1234Y1240.
54. Lee I, Chew FS. Use of IV iodinated and gadolinium contrast media in the pregnant or lactating patient: self-assessment module. AJR Am J Roentgenol. 2009;193:S70YS73.
55. Muhler MR, Clement O, Salomon LJ, et al. Maternofetal pharmacokinetics of a gadolinium chelate contrast agent in mice. Radiology. 2010;258:455-460.
56. Barkhof F, Heijboer RJ, Algra PR. Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy. AJR Am J Roentgenol. 1992; 158:1171.
57. Shoenut JP, Semelka RC, Silverman R, et al. MRI in the diagnosis of Crohn's disease in two pregnant women. J Clin Gastroenterol. 1993;17:244-247. (Pubitemid 23304506)
58. Marcos HB, Semelka RC, Worawattanakul S. Normal placenta: gadoliniumenhanced dynamic MR imaging. Radiology. 1997;205:493-496. (Pubitemid 27467331)
59. Palacios Jaraquemada JM, Bruno C. Gadolinium-enhanced MR imaging in the differential diagnosis of placenta accreta and placenta percreta. Radiology. 2000;216:610-611. (Pubitemid 30599891)
60. Rofsky NM, Pizzarello DJ, Weinreb JC, et al. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. J Magn Reson Imaging. 1994;4:805-807.